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Cornell University While a good deal of information has been accumu-
Ithaca, New York 14853 lated regarding the molecular basis by which Cdc42
directs actin cytoskeletal changes and cell polarity, rela-
tively little is known about the mechanisms used by
Cdc42 to influence cell growth. However, some cluesSummary
have emerged that implicate Cdc42 in EGF receptor-
coupled signaling and receptor processing. In particular,Cdc42 is a Ras-related protein that has been impli-
treatment of cells with EGF stimulates the activation ofcated in the control of normal cell growth, and when
Cdc42 and its interaction with specific target proteinsimproperly regulated, in cellular transformation and
(Yang and Cerione, 1997; Tu and Cerione, 2001). Oneinvasiveness. A variety of extracellular stimuli, includ-
such group of targets, the Acks (for activated Cdc42-ing epidermal growth factor (EGF), activate Cdc42.
associated kinases), comprises a family of nonreceptorHere, we show that activation of Cdc42 protects the
tyrosine kinases that recently have been implicated inEGF receptor from the negative regulatory activity of
the downregulation and degradation of the EGF receptorthe c-Cbl ubiquitin ligase. Activated Cdc42 binds to
(Lin et al., 2002).p85Cool-1 (for cloned-out-of-library)/-Pix (for Pak-
The EGF receptor activates mitogenic signaling path-interactive exchange factor), a protein that directly
associates with c-Cbl. This inhibits the binding of Cbl ways, and when either overexpressed or hyperactivated,
by the EGF receptor and thus prevents Cbl from cata- contributes to the development or progression of a wide
lyzing receptor ubiquitination. The role played by variety of human tumors (Libermann et al., 1985; Pavelic
Cdc42 in regulating the timing of EGF receptor-Cbl et al., 1993; Blume-Jensen and Hunter, 2001). EGF re-
interactions is underscored by the fact that constitu- ceptor signaling is tightly regulated through the careful
tively active Cdc42(F28L), by persistently blocking the balancing of receptor activation and trafficking, with the
binding of Cbl to these receptors, leads to their aber- latter including receptor endocytosis, degradation, and
rant accumulation and sustained EGF-stimulated ERK recycling. Recently, a significant amount of information
activation, thus resulting in cellular transformation. has come to light regarding the underlying mechanisms
of EGF receptor degradation. The degradation process
is catalyzed via a cascade of ubiquitination enzymesIntroduction
that culminates in the E3 ubiquitin ligase activity of the
Cbl adaptor proteins (Levkowitz et al., 1998, 1999;Cdc42 is a Ras-related GTP binding protein that serves
Joazeiro et al., 1999). When the ubiquitin ligase activityas a molecular switch in cells, directing a wide range of
of c-Cbl is compromised, either by mutation or deletioncellular processes and signaling activities. Traditionally,
of its ring-finger domain, the normal balance betweenCdc42 and its close relatives Rac1 and RhoA have been
EGF receptor recycling and degradation is disrupted,linked to the regulation of the actin cytoskeleton (Nobes
resulting in EGF receptor accumulation and enhancedand Hall, 1995; Kozma et al., 1995). However, a number
EGF-coupled signaling (Joazeiro et al., 1999; Watermanof lines of evidence have also implicated Cdc42, Rac1,
et al., 1999).and RhoA in the control of normal cell growth, and when
In the present work, we show that Cdc42 influencesimproperly regulated, in tumorigenesis and the develop-
the interactions of c-Cbl with the EGF receptor, as medi-ment of the metastatic state. These include the discover-
ies that members of the Dbl (for diffuse B cell lymphoma) ated by p85Cool-1/-Pix, a Cbl binding partner and a
family of guanine nucleotide exchange factors (GEFs), target/effector for Cdc42. The interaction of activated
when point-mutated or truncated, are potently trans- Cdc42 with c-Cbl prevents it from binding to the EGF
forming, and that mutations in Cdc42 which cause the receptor, thereby blocking the antagonistic actions of
spontaneous exchange of GDP for GTP are oncogenic Cbl on EGF-coupled signaling and the Cbl-catalyzed
(Cerione and Zheng, 1996; Whitehead et al., 1997; Lin ubiquitination of EGF receptors. When Cdc42 is consti-
et al., 1997). The injection of an activated form of Cdc42 tutively active, as is the case for the Cdc42(F28L) mutant,
into nude mice gives rise to tumor formation (Lin et al., the persistent sequestration of Cbl leads to a significant
1999), and the activation of Cdc42, as well as Rac1 and reduction in EGF receptor degradation, causing the re-
RhoA, are all necessary for Ras-induced malignant ceptors to accumulate and to exhibit sustained signaling
transformation (Qiu et al., 1995a, 1995b, 1997). In addi- to ERK, leading to cellular transformation. These find-
tion, Rac1 and Cdc42 have been implicated in cell inva- ings now highlight a previously unappreciated role for
Cdc42 in the regulation of EGF receptor signaling and
processing.*Correspondence: rac1@cornell.edu
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Figure 1. The Cool-1 Protein Mediates the Binding of Activated Cdc42 to c-Cbl
(A) Transient cotransfection of COS-7 cells was performed with plasmids encoding HA-tagged c-Cbl and the indicated Myc-tagged Cool-1
proteins. Anti-Myc antibody was used to immunoprecipitate Myc-tagged Cool-1 proteins from cell lysates (as detected by blotting with anti-
Myc; second image from the top). The coimmunoprecipitated HA-tagged c-Cbl was detected by Western blotting with anti-HA antibody (top
image). The lower image shows the relative expression of HA-c-Cbl in whole-cell lysates (WCL).
(B) The experimental procedure was the same as in (A) except that different forms of Myc-tagged Cdc42 were transiently cotransfected with
HA-tagged c-Cbl. The Myc-tagged Cdc42 proteins were immunoprecipitated with anti-Myc antibody (see second image from the top) and
HA-tagged c-Cbl was detected using an anti-HA antibody (top image). The lower image shows the relative expression of HA-c-Cbl in whole-
cell lysates (WCL).
(C) COS-7 cells were transiently transfected with a plasmid expressing Myc-tagged Cool-1, alone, or together with plasmids encoding the
indicated HA-tagged Cdc42 constructs. Cell lysates were subjected to immunoprecipitation with an anti-HA antibody and Western blotting
with anti-Myc to detect Cool-1 (top image) and anti-HA to detect Cdc42 (second image from the top). The lower image shows the relative
expression of Myc-tagged Cool-1 in whole-cell lysates (WCL).
(D) COS-7 cells were transiently transfected with plasmids encoding either Myc-tagged Cool-1 (upper images) or the Cool-1(W43K) mutant
(lower images). The whole-cell lysates were mixed with glutathione-agarose beads loaded with activated forms of GST-Cdc42 fusion proteins
or with GST alone. The affinity-precipitated Myc-tagged Cool-1 or Cool-1(W43K) was detected using an anti-Myc antibody.
(E) The experimental procedure was the same as in (D) except that different forms of GST fusion proteins as indicated were loaded on the
glutathione-agarose beads. The affinity-precipitated Myc-tagged Cool-1 was detected with an anti-Myc antibody (upper image). The lower
image shows the amounts of the different GST-GTP binding proteins used in the experiment.
(F) COS-7 cells were transiently transfected with an expression plasmid encoding HA-tagged c-Cbl together with a plasmid either encoding
Myc-tagged Cool-1 or Myc-tagged Cool-1(W43K). The cell lysates were mixed with glutathione-agarose beads loaded with GST-Cdc42(F28L).
The affinity-precipitated HA-tagged c-Cbl by GST-Cdc42(F28L) was detected by Western blotting with anti-HA antibody (top image). The
second image from the top shows the amount of GST-Cdc42(F28L) loaded on the beads. The two lower images show the relative expression
of HA-tagged c-Cbl and the Myc-tagged Cool-1 proteins in whole-cell lysates (WCL).
(G) COS-7 cells were transiently transfected with a pKH3 plasmid encoding triple-HA tagged wild-type Cdc42. After 24 hr of growth at 37C,
cells were either treated with 50 ng/mL EGF for 10 min or untreated. Anti-HA antibody was used to immunoprecipitate HA-tagged Cdc42
from cell lysates (lower image). The coimmunoprecipitated endogenous c-Cbl and Cool-1 were detected by Western blotting with antibodies
against c-Cbl (upper image) and Cool-1 (middle image) (Bagrodia et al., 1998).
Results breast cancer cell lines (Flanders et al., 2003). We have
found that a similar interaction occurs between c-Cbl
and Cool-1. An example is shown in Figure 1A (lane 1,The p85Cool-1/-Pix Protein Is a Binding Partner
for c-Cbl and Serves as an Interface between upper images) where Myc-tagged Cool-1 was coimmu-
noprecipitated with HA-tagged c-Cbl from COS-7 cells.Cbl and Activated Forms of Cdc42
The Cool/Pix proteins were initially identified through When Cool-1 was point-mutated within its SH3 domain
(a conserved tryptophan at position 43 was changed toyeast two-hybrid analysis and immunoprecipitation ex-
periments as binding partners for the Paks, a family a lysine), its ability to be coimmunoprecipitated with
c-Cbl was significantly reduced (lane 2). Thus, the bind-of serine/threonine kinase-targets for Cdc42 and Rac
(Bagrodia et al., 1998; Manser et al., 1998). Additional ing of c-Cbl to Cool-1 is mediated by its SH3 domain,
just like the interactions of Pak with the Cool/Pix proteinstwo-hybrid screens for Cool/Pix binding partners identi-
fied Cbl-b, a member of the Cbl family of adaptor pro- (Bagrodia et al., 1998).
We then found that c-Cbl can be coimmunoprecipi-teins that is enriched in human breast cancer cells, and
this has been further demonstrated through experiments tated with activated forms of Cdc42 (Figure 1B, upper
images). This was the case for either GTPase-defectiveshowing the coimmunoprecipitation of p85Cool-1/-Pix
(from here on called Cool-1) with Cbl-b from various Myc-tagged Cdc42(Q61L), or Cdc42(F28L) that is capa-
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Figure 2. Activated Cdc42 Inhibits the c-Cbl-Catalyzed Ubiquitination of the EGF Receptor
(A) CHO cells were transfected with an expression plasmid encoding the EGF receptor, and with plasmids encoding HA-tagged ubiquitin and
HA-tagged c-Cbl, along with the indicated Myc-tagged Cdc42 constructs. Cells were serum-starved for 12 hr and then stimulated with EGF
(100 ng/ml) for 10 min at 37C. The cell lysates were subjected to immunoprecipitation with anti-EGF receptor antibody. The ubiquitinated
EGF receptors were blotted using an anti-HA antibody (the top image). Control experiments show essentially no detectable ubiquitination of
EGF receptors in the absence of added EGF (data not shown). The expression levels of EGF receptor, HA-tagged c-Cbl and different forms
of Myc-Cdc42 in whole-cell lysates (WCL) are shown in the lower images.
(B) HEK293 cells were transiently cotransfected with plasmids encoding HA-tagged ubiquitin, the indicated forms of Myc-tagged Cdc42, HA-
tagged c-Cbl, and with a plasmid encoding either Myc-tagged Cool-1 or Myc-tagged Cool-1(W43K). Cells were serum-starved for 12 hr and
then stimulated with EGF (100 ng/mL) for 10 min. Endogenous EGF receptors were immunoprecipitated using an anti-EGF receptor antibody
(second image from the top) and the ubiquitinated EGF receptors were detected by Western blotting with anti-HA antibody (top image). The
third image from the top shows the relative amounts of HA-tagged c-Cbl that were coimmunoprecipitated with EGF receptors. The expression
levels of the different forms of Myc-Cool-1 and Myc-Cdc42 proteins, as well as HA-c-Cbl in whole-cell lysates (WCL) are shown in the three
lower images.
(C) CHO cells were serum-starved for 12 hr and stimulated with EGF (100 ng/mL) for 10 min at 37C. The tyrosine phosphorylated HA-tagged
c-Cbl was immunoprecipitated using an anti-HA antibody and detected by Western blotting with an antiphosphotyrosine antibody (4G10) (top
image). The amounts of HA-c-Cbl immunoprecipitated for each case are shown in the lower image.
(D) CHO cells were transiently transfected with plasmids encoding the EGF receptor, HA-tagged c-Cbl, the indicated Cdc42 constructs, and
a plasmid encoding Myc-tagged Cool-1(W43K). Cells were serum-starved for 12 hr and stimulated with EGF (100 ng/mL) for 10 min at 37C.
The tyrosine phosphorylated HA-tagged c-Cbl (top image) was detected as described in (C). The amount of HA-c-Cbl immunoprecipitated
for the different conditions is shown in the second image from the top. The relative expression levels of EGF receptors, Myc-Cool-1(W43K),
and different forms of Myc-Cdc42 in whole-cell lysates (WCL) are shown in the lower images.
ble of constitutive GDP-GTP exchange, whereas wild- from COS-7 cells, whereas neither wild-type (GDP
bound) Cdc42 nor the dominant-negative Cdc42(T17N)type (GDP bound) Cdc42 was incapable of this interac-
tion. As will be pointed out throughout this study, these mutant showed detectable binding to Cool-1. Likewise,
GST-Cdc42(F28L) and GST-Cdc42(Q61L) fusion pro-two activated Cdc42 mutants are interchangeable in
their abilities to associate with c-Cbl. teins were able to precipitate Myc-tagged Cool-1 from
cell lysates (Figure 1D, upper images). Mutating the con-Activated Cdc42 was also capable of forming a stable
complex with Cool-1. The Cool/Pix proteins were origi- served tryptophan within the SH3 domain of Cool-1 did
not affect its ability to bind to activated Cdc42 (Figurenally assumed to serve as guanine nucleotide exchange
factors (GEFs) for Rho family GTP binding proteins 1D, lower images), indicating that Cdc42 binds to Cool-1
independent of Pak [i.e., Pak can not bind to the Cool-because they contain the characteristic tandem ar-
rangement of Dbl-homology (DH) and pleckstrin-homol- 1(W43K) mutant (Bagrodia et al., 1998)]. The Cool-1 pro-
tein binds preferentially to activated Cdc42, since bothogy (PH) domains. However, Cool-1 does not exhibit
GEF activity because of the presence of a unique se- activated versions of Rac or RhoA [Rac(Q61L) and
RhoA(Q63L)] showed either weak or no detectable bind-quence that lies downstream from the PH domain (Feng
et al., 2002), but rather binds preferentially to ac- ing (Figure 1E).
The ability of c-Cbl to associate with activated formstivated versions of Cdc42. Figure 1C (upper image)
shows that Myc-tagged Cool-1 was coimmunoprecipi- of Cdc42 requires Cool-1. Figure 1F (upper image)
shows the results of an experiment examining the abilitytated with HA-tagged, GTPase-defective Cdc42(Q61L)
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of GST-Cdc42(F28L) to precipitate HA-tagged c-Cbl Cool-1 did not reverse the Cdc42(F28L)-mediated inhibi-
tion of EGF receptor ubiquitination (lane 5 in the topfrom cells that expressed either Myc-tagged, wild-type
Cool-1 (lane 1), or the Cool-1 construct that was point image of Figure 2B). Thus, the Cool-1(W43K) protein
acted as a dominant-negative mutant, blocking the pro-mutated in its SH3 domain (W43K) and has a weakened
affinity for c-Cbl (lane 2). When the Cool-1(W43K) mutant tection afforded by activated Cdc42 against EGF recep-
tor ubiquitination by preventing the binding of Cdc42 towas coexpressed with c-Cbl, it acted as a dominant-
negative mutant by inhibiting the binding of endogenous endogenous Cool-1 and HA-tagged c-Cbl.
The c-Cbl protein binds to autophosphorylated EGFCool-1 to activated Cdc42 and reduced the amount of
c-Cbl that was coprecipitated with Cdc42. We found receptors through its variant SH2 domain. Activated
Cdc42, by binding to Cool-1 and thereby indirectly asso-the same to be true when examining the coprecipitation
of c-Cbl with the GTPase-defective GST-Cdc42(Q61L) ciating with HA-tagged c-Cbl, prevents c-Cbl from bind-
ing to activated EGF receptors. This can be seen whenprotein (data not shown).
Given that activated versions of Cdc42 associate with monitoring the ability of HA-Cbl to be coimmunoprecipi-
tated with the EGF receptor in an EGF-dependent man-Cool-1 and c-Cbl, we then asked whether the treatment
of cells with EGF promoted the formation of a complex ner (compare lanes 2 and 3 in the third image from the
top in Figure 2B). Coexpression of the Cool-1(W43K)between Cdc42, Cool-1, and c-Cbl. COS-7 cells were
transiently transfected with triple-HA-tagged wild-type mutant with Cdc42(F28L) fully restored the ability of
HA-Cbl to bind to the EGF receptor, whereas wild-typeCdc42 and then treated with EGF for 10 min, a time
period that is sufficient to activate fully Cdc42 (Tu and Cool-1 did not alter the ability of Cdc42(F28L) to block
the binding of Cbl to the receptors (see lanes 4 and 5,Cerione, 2001). As shown in Figure 1G, when Cdc42
was immunoprecipitated with an anti-HA antibody, both respectively, in the third image from the top, Figure 2B).
As an outcome of binding to EGF receptors, c-Cbl isendogenous c-Cbl and Cool-1 were coimmunoprecipi-
tated with Cdc42 in an EGF-dependent manner. phosphorylated in an EGF-dependent manner (Figure
2C, top image), an event that is necessary for Cbl to
exhibit ubiquitin ligase activity (Levkowitz et al., 1998,Cdc42 Blocks the c-Cbl-Catalyzed Ubiquitination
1999). By blocking the binding of c-Cbl to the EGF recep-of the EGF Receptor
tor, we suspected that activated Cdc42 would also in-It has been shown that c-Cbl serves as an E3 ubiquitin
hibit the EGF-stimulated tyrosine phosphorylation ofligase that catalyzes the ubiquitination and degradation
Cbl. To examine this possibility, the EGF receptor andof EGF receptors (Levkowitz et al., 1998; Joazeiro et al.,
HA-tagged c-Cbl were first coexpressed along with dif-1999; Waterman et al., 1999). These findings, when taken
ferent constructs of activated Myc-tagged Cdc42 intogether with the results described in the preceding
CHO cells. The cells were treated with EGF and thensection, raise the question of whether Cdc42 influences
HA-tagged c-Cbl was immunoprecipitated and analyzedthe c-Cbl-catalyzed ubiquitination of EGF receptors. We
by Western blotting with an antiphosphotyrosine anti-have examined this possibility using CHO (Figure 2A)
body (4G10). The EGF-dependent phosphorylation ofand HEK293 (Figure 2B) cells because they have proven
c-Cbl was strongly inhibited upon the expression of con-to be two excellent model systems for assaying EGF
stitutively active forms of Cdc42 [i.e., both Cdc42(Q61L)receptor ubiquitination (Levkowitz et al., 1999). Consis-
and Cdc42(F28L); Figure 2D, compare lane 1 with lanes 2tent with previous reports (Levkowitz et al., 1998), the
and 3, respectively, top image], whereas when activatedcoexpression of HA-tagged c-Cbl together with the EGF
Cdc42 was coexpressed with the Cool-1(W43K) mutantreceptor and HA-tagged ubiquitin in CHO cells signifi-
(lanes 5 and 6, top image), the tyrosine phosphorylationcantly increased the incorporation of HA-ubiquitin into
of c-Cbl was restored to levels ranging from 30%–75%the EGF receptor, compared to cells expressing EGF
of that observed in the absence of activated Cdc42.receptors and ubiquitin in the absence of HA-Cbl (Figure
2A, compare lanes 1 and 2, in the top image). The expres-
sion of wild-type Cdc42 yielded a modest reduction in Association of Cdc42 with Cool-Cbl Complexes
Requires the Rho-Insert Region of Cdc42the extent of receptor ubiquitination (lane 3, top image).
However, both GTPase-defective Cdc42(Q61L) and the Removal of the Rho-insert region from Cdc42, a se-
quence of 13 amino acids (122–134) that is unique toconstitutively active Cdc42(F28L) caused significant re-
ductions in receptor ubiquitination (compare lanes 4 and Rho-related proteins but missing in Ras, has no effect on
the binding of CRIB (for Cdc42/Rac-interactive binding)5 with lane 2 in Figure 2A, top image).
Similar results were obtained in HEK293 cells, domain-containing targets like Pak to activated Cdc42
(Wu et al., 1998). However, deleting the Rho-insert fromwhere the EGF-stimulated ubiquitination of endogenous
EGF receptors was inhibited upon expression of the either a Cdc42(Q61L) or Cdc42(F28L) background signif-
icantly diminishes the ability of activated Cdc42 to asso-Cdc42(F28L) protein (compare lanes 2 and 3 in the top
image of Figure 2B). This inhibition was reversed when ciate with endogenous Cool-1. An example is shown
in Figure 3A, using the GST-Cdc42(Q61L) protein. TheCdc42(F28L) was coexpressed with the Cbl binding-
defective Cool-1(W43K) mutant (lane 4) and in fact ap- weakened binding of Cool-1 to activated Cdc42 molecules
lacking the Rho-insert [Cdc42(L8/Q61L)], compared topeared to give rise to a stronger degree of receptor
ubiquitination, although in several experiments the ex- Cdc42(Q61L) (Figure 3A, top image, see lanes 1 and 2,
respectively), is accompanied by a marked reductiontent of receptor ubiquitination detected in the presence
of the W43K mutant was typically within 10% of that for in the coimmunoprecipitation of c-Cbl with activated
Cdc42. This is shown in Figure 3B (top image), whichcells transfected with c-Cbl alone (lane 3). Wild-type
Cdc42 Regulates EGF Receptor Degradation
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Figure 3. The Rho-Insert Region of Cdc42 Is Required for Protection against the c-Cbl-Catalyzed Ubiquitination of the EGF Receptor
(A) Whole-cell lysates prepared from NIH 3T3 cells were mixed with GST beads loaded with equivalent amounts of GST-Cdc42(Q61L) and
GST-Cdc42(L8/Q61L) fusion proteins (see lower image). The affinity-precipitated endogenous Coo1-1 and Pak3 proteins were detected by
Western blotting with anti-Cool-1 (top image) or anti-Pak3 (middle image) antibodies.
(B) COS-7 cells were transiently cotransfected with plasmids encoding HA-c-Cbl, and either Myc-tagged Cool-1 or different forms of Myc-
tagged Cdc42. Myc-tagged Cool-1 (second image from the top) and Cdc42 (third image from the top) were immunoprecipitated with anti-
Myc antibody from cell lysates and detected by Western blotting with anti-Myc antibody. The coimmunoprecipitated HA-tagged c-Cbl was
detected by Western blotting with anti-HA antibody (top image). The relative expression levels of HA-c-Cbl are shown in the bottom image.
(C) The experimental procedures were essentially the same as in Figure 2A except that Cdc42(L8/Q61L) was tested for its ability to protect
against the c-Cbl-mediated ubiquitination of the EGF receptor. The top images show the relative levels of EGF receptor ubiquitination, as
assayed by the incorporation of HA-tagged ubiquitin, and the lower image shows the relative amounts of EGF receptor in the different cells.
compares the ability of HA-tagged c-Cbl to be coimmu- Cool-Cbl complex was essential for Cdc42-mediated
cellular transformation.noprecipitated with either Myc-tagged Cdc42(Q61L)
(lane 3), Cdc42(Q61L) that lacks the Rho-insert (lane
4), or with dominant-negative Cdc42(T17N) (a negative The Interaction between Cdc42 and the Cool-Cbl
Complex Is Essential for Cdc42-Inducedcontrol; lane 5). As an additional positive control, the
ability of Myc-tagged Cool-1 to be coimmunoprecipi- Cellular Transformation
If the above stated idea were correct, we would expecttated with HA-tagged c-Cbl is shown in lane 2.
Figure 3C shows that the Cool-1 binding-defective that mutations that block the interactions of Cool-1 with
c-Cbl, and thus prevent the formation of a Cdc42-Cool-Cdc42(L8/Q61L) mutant was unable to protect against
the Cbl-catalyzed ubiquitination of the EGF receptor. Like- Cbl complex, would act in a dominant-negative fashion
to inhibit Cdc42-mediated transformation. One suchwise, removal of the insert region from the Cdc42(F28L)
background eliminates the ability of Cdc42 to stimulate mutant is the Cbl binding-defective Cool-1(W43K) pro-
tein, whereas another is a carboxy-terminal truncatedcolony formation in soft agar (also, Wu et al., 1998).
Thus, taken together, these results led us to suspect form of c-Cbl that contains the amino terminal 480 resi-
dues (designated as c-Cbl-N480) and still exhibits E3that the ability of activated Cdc42 to associate with the
Cell
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Figure 4. Expression of the Amino-Terminal Half of c-Cbl or Cool-1(W43K) Blocks Cdc42(F28L)-Mediated Cellular Transformation
(A) Growth profiles (1% serum) for control (vector) NIH 3T3 cells, and cells stably expressing a c-Cbl protein that lacks the proline-rich Cool-1
binding region (residues 1–480, designated c-Cbl-N480), Cdc42(F28L) alone, and Cdc42(F28L) together either with Cool-1(W43K) [designated
Cdc42(F28L)W43K] or with c-Cbl-N480 [designated Cdc42(F28L)N480]. #26 and #32 indicate two clones of Cdc42(F28L)N480 with different
expression levels of c-Cbl-N480. Data represent the average of three experiments. The lower images show Western blots comparing the
relative expression in whole-cell lysates (WCL) of Cdc42(F28L), c-Cbl-N480, and Cool-1(W43K).
(B) Photomicrograph of the different NIH 3T3 cells described in (A). Cells were cultured in 1% calf serum for 6 days.
(C) Anchorage-independent growth of control (vector) NIH 3T3 cells and cells stably expressing Cdc42(F28L), Cdc42(F28L) with c-Cbl-N480
[designated Cdc42(F28L)N480 (clone #32)], or Cdc42(F28L) with Cool-1(W43K) [designated Cdc42(F28L)W43K]. Cell colonies were scored
after 14 days. Data represent the average of three experiments.
(D) Photomicrograph of the colony formation of the cells in soft agar, as described in (C).
ubiquitin ligase activity (Joazeiro et al., 1999) but lacks agar was also examined (Figures 4C and 4D). The latter
has typically been described as the most reliable indica-the proline-rich stretch that is essential for binding to
Cool-1. We thus examined the effects of both mutants tor of malignant transformation. Here again, we saw that
the expression of c-Cbl-N480 or Cool-1(W43K) blockedon the ability of the constitutively active, transforming
Cdc42(F28L) protein to stimulate the growth of NIH 3T3 Cdc42(F28L)-induced cellular transformation.
fibroblasts in low serum (Figures 4A and 4B). Control
cells expressing vector alone grow poorly in 1% serum, Expression of Cdc42(F28L) Results
in an Accumulation of EGF Receptorswhereas cells stably expressing the Cdc42(F28L) mutant
grow very effectively under these conditions. However, and Sustained EGF-Coupled Signaling
The results described in the previous sections lead towhen the Cdc42(F28L) mutant was coexpressed with
different amounts of c-Cbl-N480, there was a marked the question of how do the interactions between
Cdc42(F28L), Cool-1, and c-Cbl give rise to cellularinhibition of cell growth in low serum, with the extent of
inhibition corresponding to the relative amount of c-Cbl- transformation. Since Cbl-catalyzed ubiquitination is
necessary for the degradation of EGF receptors, theN480 expressed (see the different relative levels of ex-
pression of c-Cbl-N480 in the Western blots just below stable expression of Cdc42(F28L) in NIH 3T3 cells, by
sequestering c-Cbl, may result in an accumulation ofthe image for the growth curves in 4A). Expression of
increasing amounts of the Cbl binding-defective Cool- EGF receptors and/or sustained EGF-coupled signaling,
which in turn could contribute to cellular transformation.1(W43K) mutant also resulted in a corresponding inhibi-
tion of Cdc42(F28L)-stimulated growth in low serum Figures 5A and 5B show that following the addition of
EGF to control fibroblasts, total receptor levels as de-(data not shown), and this culminated with the Cool-
1(W43K) mutant causing the complete elimination of the tected by Western blotting with an anti-EGF receptor
antibody were significantly reduced over a time periodtransformation phenotype (Figures 4A and 4B).
The effects of the Cbl and Cool-1 mutants on the of 5–45 min. While the kinetics for EGF receptor down-
regulation were slightly reduced in cells expressing on-ability of Cdc42(F28L) to induce colony formation in soft
Cdc42 Regulates EGF Receptor Degradation
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Figure 5. The EGF Receptor Accumulates in Cells Expressing Cdc42(F28L)
(A) NIH 3T3 cells that stably expressed the indicated Cdc42 proteins, Ras(G12V), Cdc42(F28L) together with Cool-1(W43K) [designated
Cdc42(F28L)W43K], or vector control were seeded in 6-well plates and serum-starved for 12 hr prior to EGF (100 ng/ml) stimulation for the
indicated times at 37C. The levels of EGF receptor were assessed by Western blot analysis of the cell extracts using an anti-EGF receptor
antibody. The expression of the different Cdc42 constructs was essentially identical in the different cell lines (data not shown). The accumulation
of EGF receptors that occurs over a 6 hr period in cells expressing Cdc42(F28L) has been observed in three different cell lines that stably
express this mutant.
(B) The EGF receptor levels for Cdc42(F28L)-transformed cells and vector control cells were quantified using ImageScanner (Amersham
Pharmacia Biotech) with total Lab Software version 1.0. The relative levels of EGF receptor were normalized to the levels detected at zero time.
(C) Control (vector) NIH 3T3 cells, cells stably expressing the indicated Cdc42 proteins, or cells expressing Cdc42(F28L) together with
Cool-1(W43K) [designated Cdc42(F28L)W43K], were seeded on dual chamber slides and serum-starved for 12 hr prior to exposure to
tetramethylrhodamine-labeled EGF (0.5 g/mL) at 4C for 1 hr. Cells were warmed to 37C for the indicated times, transferred to ice, and
stripped to remove surface bound EGF. The red punctated structures indicate tetramethylrhodamine-labeled EGF-receptors.
(D) Time course for the EGF-dependent activation of ERK in cells expressing Cdc42(F28L), Cdc42(L8/F28L), Cdc42(F28L) together with Cool-
1(W43K) [designated Cdc42(F28L)W43K], Ras(G12V), or vector control. Anti-phospho-p44/42 ERK was used to detect activated p44/42 ERK.
cogenic Ras (Figure 5A), consistent with other reports of Cdc42(F28L)-expressing cells that were exposed to EGF
for 30 min, compared to control cells or cells expressing(Waterman and Yarden, 2001), the receptor levels were
nonetheless significantly decreased after 2 hr of incuba- either the Cdc42(L8/F28L) mutant or Ras(G12V) (data
not shown). Figure 5C shows immunofluorescence im-tion with EGF. However, cells expressing Cdc42(F28L)
showed a marked reduction in the rate of EGF receptor ages of rhodamine-labeled EGF bound to the receptor,
as a function of time of treatment with the labeled growthdownregulation, such that EGF receptors were still de-
tected after 6 hr of incubation with EGF (Figures 5A and factor. In control cells, EGF receptor levels were signifi-
cantly reduced within 15 min of treatment with labeled5B). The protective effects exhibited by Cdc42(F28L)
were not observed in cells expressing the Cool-1 bind- EGF. However, in Cdc42(F28L)-expressing cells, EGF
receptors were detectable through 2 hr of treatmenting-defective Cdc42(L8/F28L) mutant, nor in cells
expressing Cdc42(F28L) together with the Cbl binding- with labeled EGF, with the receptors accumulating in
intramembrane (endosomal) compartments. Receptordefective Cool-1(W43K) mutant (Figure 5A), demon-
strating that this protection requires the interaction of accumulation was not observed in cells expressing the
Cdc42(L8/F28L) mutant or in cells expressingactivated Cdc42 with Cool-1 and Cbl.
The accumulation of EGF receptors in Cdc42(F28L)- Cdc42(F28L) together with Cool-1(W43K).
The results presented in Figure 5D show that in controlexpressing cells was not the result of changes in recep-
tor endocytosis. The rates for EGF receptor endocytosis NIH 3T3 cells, as well as in cells expressing Cdc42(L8/
F28L), or cells expressing Cdc42(F28L) together within control fibroblasts and in fibroblasts expressing
Cdc42(F28L), when assaying the uptake of [125I]-EGF Cool-1(W43K), the EGF-stimulated activation of ERK
peaked within 5 min and was lost within 15 min, duebound receptor, were identical, although there were at
least 3–5-fold higher levels of receptor on the surface to receptor downregulation. However, in fibroblasts ex-
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Figure 6. EGF Receptor Activity Is Required for Cdc42-Induced Cellular Transformation
(A) NIH 3T3 cells stably expressing Cdc42(F28L) or Ras(G12V) were cultured in the presence of 1% calf serum with or without AG1478 (4 M)
and then at the indicated times, trypsinized, and counted. Data represent the average of three experiments.
(B) Effects of the tyrphostin AG1478 on the transformed morphology of cells expressing Cdc42(F28L) and Ras(G12V). The cells were cultured
under the same conditions as described in (A) for 6 days.
(C) The experimental procedures were essentially the same as in (A) except that the culture media contained 5 M PD98059.
(D) Effects of PD98059 on the transformed morphology of cells expressing Cdc42(F28L) and Ras(G12V).
pressing Cdc42(F28L), EGF-stimulated ERK activation this inhibitor (Figures 6C, left image, and 6D). Taken
together, these results are consistent with the idea thatwas still detected after 6 hr of treatment with EGF.
Overall, these results suggested the possibility that the ability of activated Cdc42 to cause an accumulation
of EGF receptors and enhanced EGF-coupled signalingthe accumulation and sustained signaling of EGF recep-
tors in Cdc42(F28L)-expressing cells were responsible to ERK in NIH 3T3 cells, may underlie the Cdc42-medi-
ated transformation of these cells.for their transformed phenotype. The results presented
in Figure 6A (left image) show that the addition of the
tyrphostin AG1478, a specific inhibitor of EGF receptor
tyrosine kinase activity (Levitzki and Gazit, 1995), to cells Discussion
stably expressing Cdc42(F28L) markedly inhibited their
ability to grow in low serum. The identical treatment EGF Receptor Degradation Is Regulated by Cdc42
Here we describe a previously unappreciated relation-of cells stably expressing the oncogenic Ras protein,
Ras(G12V), did not result in growth inhibition (right im- ship between EGF receptor signaling and Cdc42. The
ability of EGF receptors to be degraded is markedlyage). Cells that stably expressed Cdc42(F28L), when
cultured in 1% calf serum plus AG1478, also lost their reduced in cells that express activated versions of
Cdc42. Following endocytosis, EGF receptors are tar-transformed morphology whereas cells expressing
Ras(G12V) were unaffected by treatment with the inhibi- geted for degradation via an ubiquitination reaction cat-
alyzed by the Cbl adaptor proteins (Levkowitz et al.,tor (Figure 6B). The inability of AG1478 to inhibit
Ras(G12V)-induced transformation was not unexpected. 1998, 1999; Joazeiro et al., 1999; Waterman et al., 1999).
The c-Cbl protein represents the protooncogenic formBecause Ras(G12V) is always in the GTP bound state,
it does not require receptor kinase activity to promote of the viral Cbl transforming gene of the CAS NS-1 retro-
virus, which has been shown to induce pre-B lymphomaits activation, as indicated by the ability of Ras(G12V)
to fully activate ERK in the absence of EGF treatment and myeloid leukemia (Langdon et al., 1989), and is the
mammalian homolog of the C. elegans EGF receptorand in a sustained manner despite EGF receptor down-
regulation (see the lowest image in Figure 5D). However, antagonist Sli-1 (Yoon et al., 1995). The Cbl proteins use
a nonconventional SH2 domain to bind to a specificunlike the case for Ras, the ability of the constitutively
active Cdc42(F28L) protein to stimulate cell prolifera- autophosphorylation site on the EGF receptor. The en-
suing EGF-stimulated tyrosine phosphorylation of Cbl,tion appears to require EGF receptor activation. Cdc42-
mediated transformation also requires activation of the which occurs in a region connecting its SH2 and ring
finger domains, results in the recruitment of an ubiquitin-Ras-ERK pathway. Figures 6C (right image) and 6D show
that when Cdc42(F28L)-expressing cells were treated loaded E2 molecule and the activation of an E3 ligase
activity that mediates the attachment of ubiquitin towith the MEK inhibitor, PD98059, which blocks signaling
from activated Ras to ERK, Cdc42-induced cellular the receptor.
A working model for the Cdc42-mediated regulationtransformation was inhibited, similar to what was ob-
served when treating Ras(G12V)-expressing cells with of Cbl, based on a number of lines of experimental evi-
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the regulatory effects imparted by Cdc42 provide the
added advantage that they are finite in duration, as GTP
hydrolysis, which converts Cdc42 to an inactive state
and causes it to dissociate from Cool-1, would allow
Cbl to bind to the EGF receptor and ensure that EGF-
coupled signaling occurs for a finite time period and is
ultimately terminated. The reversible regulation of Cbl
by Cdc42 can also be distinguished from that of c-Src,
which has recently been shown to catalyze the phos-
phorylation of c-Cbl and likely leads to its irreversible
destruction through ubiquitination and proteasomal
degradation (Bao et al., 2002). On the other hand, muta-
tions that allow Cdc42 to become constitutively active
(e.g., the F28L mutation) would be expected to alter the
timing of Cbl-catalyzed EGF receptor ubiquitination, as
Figure 7. Model Depicting the Cdc42-Mediated Regulation of EGF increased amounts of activated Cdc42 would compete
Receptor Interactions with c-Cbl with the EGF receptor for Cbl (through the binding of
In this scheme, EGF receptor activation stimulates GDP-GTP ex- activated Cdc42 to Cool-1 and Cbl), thereby inhibiting
change on both Ras and Cdc42, resulting in the formation of receptor degradation and giving rise to sustained EGF-
Cdc42•GTP-Cool-Cbl complexes and signaling through the Ras-
coupled signaling.ERK pathway. When Cdc42 hydrolyzes GTP, it dissociates from
Thus, Cdc42-mediated cellular transformation may beCool-1. This enables Cbl to bind to the EGF receptor and to be
a consequence of the sustained mitogenic signaling thatphosphorylated, thus activating Cbl’s E3 ligase activity and allowing
it to catalyze receptor ubiquitination and degradation. For sake of accompanies the inhibition of EGF receptor-Cbl interac-
simplicity, we show that c-Cbl, alone, rather than a Cool-Cbl com- tions by constitutively active Cdc42. This would be con-
plex, binds to the EGF receptor, as we have not found Cool-1 to be sistent with our findings that both a carboxy-terminal-
coimmunoprecipitated with the EGF receptor. This may mean that
truncated Cbl protein and the Cool-1(W43K) mutant,Cool-1 dissociates from Cbl once it binds to and/or is phosphory-
which are defective for the formation of a Cdc42-Cool-lated by the EGF receptor.
1-Cbl complex, block Cdc42-mediated transformation.
This would also explain the apparent requirement for
EGF receptor tyrosine kinase activity that is associateddence, is presented in Figure 7. It begins with the EGF-
with the proliferation of Cdc42(F28L)-expressing cells,dependent activation of Cdc42, which promotes the as-
as well as highlight the fundamental differences in thesociation of this GTP binding protein with Cool-1 and
mechanisms underlying cellular transformation bythus indirectly with Cbl. This blocks the binding of Cbl
Cdc42 versus Ras, as oncogenic Ras is not sensitive toto the EGF receptor and thereby exerts a two-pronged
EGF receptor tyrosine kinase inhibitors and does noteffect on the ability of Cbl to act as an E3 ligase, first
give rise to EGF receptor accumulation. Moreover, ourby preventing Cbl from engaging its ubiquitination sub-
findings now provide an explanation for the requirementstrate (i.e., the EGF receptor), and secondly, by not
of the Rho-insert region for Cdc42(F28L)-mediatedallowing Cbl to be phosphorylated by the EGF receptor,
transformation (Wu et al., 1998). Activated Cdc42 mole-which is necessary for the manifestation of Cbl’s E3
cules which lack the Rho-insert region, while still ableubiquitin ligase activity (Levkowitz et al., 1999). The abil-
to bind to a number of known target/effectors for Cdc42ity of activated Cdc42 to inhibit the binding of Cbl to
including the Paks, Acks, and -coatomer subunit (Wuthe EGF receptor, and the ensuing Cbl-catalyzed ubiqui-
et al., 2000), show a markedly diminished capability fortination of the receptor, was reversed upon expression
binding Cool-1. This would prevent Cdc42 from seques-of the Cool-1(W43K) mutant that still binds to activated
tering Cbl and from inhibiting receptor ubiquitinationCdc42 but is defective in binding to Cbl. Activated Cdc42
and degradation.proteins that can not bind Cool-1 because of the removal
The present findings also raise some interesting impli-of the Rho-insert region are ineffective at protecting
cations and questions regarding malignant transforma-against Cbl-catalyzed ubiquitination of the EGF recep-
tion and human cancers. It has been well documentedtor. While Cool-1, alone, is able to bind to Cbl, we do
that EGF receptors are present in excessive amountsnot find it to be sufficient (i.e., when overexpressed)
in various breast cancer cells, as well as in glioblastomasto block the Cbl-catalyzed ubiquitination of the EGF
and other tumors (Libermann et al., 1985; Pavelic et al.,receptor (data not shown). Thus, the binding of activated
1993; Blume-Jensen and Hunter, 2001). In most cases,Cdc42 to a Cool-Cbl complex may sterically interfere
the specific mechanisms underlying the increased levelswith the binding of Cbl to the EGF receptor.
of receptor are not known, although they often can not
be attributed to gene amplification, and so they mayImplications for the Role of Cdc42 in EGF Receptor
arise through an alteration in the normal uptake or degra-Signaling and Cell Growth Control
dation of the receptor. In light of the present findings,The effects of activated Cdc42 and Cool-1 on Cbl func-
it might also be expected that alterations in the normaltion share some similarity with those reported for the
functioning of other control points in the trafficking path-human Sprouty2 protein, which was recently shown to
way of the EGF receptor may contribute to these can-be capable of attenuating EGF receptor ubiquitination
cers, for example, as manifested by the aberrant activa-and receptor endocytosis, and to cause enhanced EGF-
stimulated ERK activation (Wong et al., 2002). However, tion of Cdc42.
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ling. Nature 411, 355–365.
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